top of page

fresnel lens hero.jpg

News & Events

background (41).jpg

March 9, 2022

SpineThera to Present at WVSIPP Incube Meeting in Conjunction with ASPN Think Tank

September 27, 2021

SpineThera Announces Addition of Vice President of Global Clinical Operations to Management Team

July 26, 2021

SpineThera Announces Issuance of Fourth and Fifth Patents Covering its Sustained-Release Platform Technology

November 25, 2019

SpineThera announces first patient dosed in salient phase 1/2 clinical study SX600, an investigational non-opioid epidural steroid injection is being evaluated for the treatment of sciatica

August 22, 2019

SpineThera receives u.s. patent covering sustained-release injectable corticosteroid, SX600, a non-opioid drug in development for low back pain

October 22, 2018

Purdue Pharma L.P. Enters into Exclusive Option Agreement to Acquire SpineThera, Inc. and Its Non-Opioid Product in Development for Epidural Steroid Injection for the Treatment of Low Back Pain

October 10, 2017

SpineThera to Present at Discovery Square Innovators & Investors Forum

October 4, 2017

SpineThera Featured as a Minnesota Company Working On Alternatives for Opioid Pain Medication

yes lens fade.jpg

bottom of page